Temple University Health System’s preparations for and treatment of patients amidst the coronavirus pandemic continue to be part of the media’s COVID-19 coverage.
- Roberto Caricchio, MD, FACR, Chief of the Section of Rheumatology, Professor of Medicine and Professor of Microbiology and Immunology at the Lewis Katz School of Medicine at Temple University (LKSOM) and Director of the Temple Lupus Program at Temple University Hospital (TUH), is the lead author on a new report published online in the Annals of the Rheumatic Diseases that is the first to identify criteria that can be readily used in clinical practice to potentially head off the worst of a hyper-immune attack known as cytokine storm, raising the possibility for early therapeutic intervention in COVID-19 patients. The breakthrough is the result of an extensive collaboration between researchers and clinicians across multiple departments in LKSOM and TUH and was highlighted by 6ABC, CBS3, NBC10 and the Philadelphia Inquirer.
- Dr. Caricchio also spoke with the Philadelphia Inquirer about the increase in cases of COVID-19 in Pennsylvania and New Jersey, but not – so far – in hospitalizations.
- The Philadelphia Tribune featured perspective from Delana Wardlaw, MD, who practices at Temple Physicians Inc. at Nicetown, on the recent increase in coronavirus cases in Pennsylvania.